cancer cells

ONCOLOGY WEBINAR SERIES

Translating Radiolabeled Biologics – Strategies for Successful IND Submission

Vince Carroll, Ph.D. | Senior Director of Radiochemistry, Invicro

Ohad Ilovich, Ph.D. | Senior Director of Translational Research, Invicro

Segmentation of Lesions in Whole-Body PET/CT Using Deep Learning

Tyler Wellman, Ph.D. | Associate Director Oncology,  Invicro

Utilizing Imaging Agent Biomarkers for Improved Patient Management – Challenges and Successes

Ohad Ilovich, Ph.D. | Senior Director Translational Research, Invicro

Gisela Montgomery, M.D., Ph.D. | Medical Director (SMS), Invicro

Panel Discussion - PSMA: Imaging Biomarker Development

(Moderator: Matthew Silva, Ph.D. | CEO, Invicro)

Michael Groaning, Ph.D. | US Medical Advisor – Prostate Cancer, Novartis 

Marco Gottardis, Ph.D. | Vice President of Oncology and Innovation Leader, Janssen

Mark Salvati, Ph.D. | Executive Director, Global Product General Manager, Amgen Oncology Early Development

Jacob Hesterman, Ph.D. | Founding Partner and Chief Technology Officer, Invicro

Phillip Kuo, M.D.,Ph.D. | Senior Medical Director, Invicro

The Changing Landscape of Response Assessment in Oncology

Larry Schwartz, M.D. | Radiologist, Columbia Vagelos College of Physicians and Surgeons

Next Generation Tissue Biomarker Assays to Advance Clinical Drug Development Applications

Kenneth Bloom, M.D., FCAP | Chief Medical Officer for Advanced Pathology and Genomic Services, Invicro

Optimization of a Novel Tissue Test to Visualize and Quantify Membrane PSMA Expression in  Prostate Cancer

Hemi Dimant, Ph.D. | Director of Applications for Advanced Pathology Services, Invicro

Julie Bailis, Ph.D. | Director of Research, Inflammation/Oncology, Amgen

Uncovering New Biological Insights Using Advanced Pathology Image Analysis Tools

Joseph Krueger, Ph.D. | Vice President, Research and Applications for Advanced Pathology Services, Invicro

The Digital Biomarker Revolution: How Large-Scale, Clinical-Grade AI Enables Novel CDXs from Histopathology

Thomas Fuchs, Dr.sc. | Founder and Chief Scientific Officer, Paige

Development of Novel PET Radioligands for PET Imaging Applications ​

Lisa Wells, BSc Hons, Ph.D. | Head of Discovery CNS Applications, Invicro

Utilization of 3D Fluorescent Imaging in Multi-modality Studies

Hemi Dimant, Ph.D. | Director of Applications for Advanced Pathology Services, Invicro

Image Acquisition is Easy; Constructing Robust Data Analysis Workflows is the Challenging and Critical Part

Kyle Kuszpit | Head, Preclinical PET/CT Imaging, AstraZeneca

Applications of Machine Learning in Medical Image Analysis

Elliot Greenblatt, Ph.D. | Associate Director of CT and Advanced Special Projects, Invicro

Chemistry External Manufacturing and Network Management

Denise Ferraiolo, B.A. | Senior Vice President, Clinical Operations, Invicro

Jeff Norenberg, PharmD, Ph.D. | Vice President, Chemistry, Invicro

Machine Learning & Deep Learning For Image Processing Applications

Jacob Hesterman, Ph.D. | Founding Partner and Chief Technology Officer, Invicro

Brian Avants, Ph.D. | Senior Director of Machine Learning, Invicro

Machine Learning and Deep Learning for Image Processing Applications

Jacob Hesterman, Ph.D. | Founding Partner and Chief Technology Officer, Invicro

Brian Avants, Ph.D. | Senior Director of Machine Learning, Invicro

Obtaining High Quality Imaging Data from Clinical Trials

Justin Albani | Director of Imaging Services, Invicro

Lino Becerra, Ph.D. | Vice President MRI, Invicro

Imaging in Immuno-Oncology

Chaitanya Divgi, M.D. | Senior Medical Director, Oncology Imaging, Invicro
 
David Leung, M.D., Ph.D. | Medical Director for Oncology Imaging, Bristol-Myers Squibb
 
 

Tissue-based Biomarker Imaging Applications for Oncology Drug Discovery and Development

Joseph Krueger, Ph.D. | VP of Research and Applications for Advanced Pathology Services, Invicro

 

Image Acquisition is Easy; Constructing Data Analysis Workflows that Work for you is the Challenging and Critical Part

Kyle Kuszpit | Head, Preclinical PET/CT Imaging, AstraZeneca

Applications of Machine Learning in Medical Image Analysis

Elliot Greenblatt, Ph.D. | Associate Director of CT and Advanced Special Projects, Invicro

How MRI is Helping to De-risk Drug Development

Lino Becerra, Ph.D. | VP MRI, Invicro
 
 

How MRI is Helping to De-risk Drug Development

Lino Becerra, Ph.D. | VP MRI, Invicro

Translational Aspects of Intrathecal Drug Administration: Models, Methods and Dosimetry

Jacob Hesterman, Ph.D. | Founding Partner and Head of R&D, Invicro
 
Howard Dobson, BVM&S, DVSC | Senior Director of Scientific and Medical Services, Invicro

Translational Aspects of Intrathecal Drug Administration: Models, Methods and Dosimetry

Jacob Hesterman, Ph.D | Founding Partner and Head of R&D, Invicro

Howard Dobson, BVM&S, DVSC | Senior Director of Scientific and Medical Services, Invicro

 

Imaging Biomarkers in Metastatic Prostate Cancer

Matthew Silva, Ph.D. | CEO, Invicro
 
Phillip Kuo, M.D., Ph.D. | Senior Medical Director, Invicro

Imaging Biomarkers in Metastatic Prostate Cancer

Matthew Silva, Ph.D. | CEO, Invicro
 
Phillip Kuo M.D., Ph.D. | Senior Medical Director, Invicro

Molecular Imaging and Alpha-Radiopharmaceutical Therapy

Ohad Ilovich, Ph.D. | Director of Translational Research, Invicro

Kelly Orcutt, Ph.D. | VP of Discovery Research, Invicro

Chaitanya Divgi, M.D. | Lead Scientist & Clinician, Oncology Imaging, Invicro

Molecular Imaging and Alpha-Radiopharmaceutical Therapy

Chaitanya Divgi, M.D. | Lead Scientist & Clinician, Oncology Imaging, Invicro

Ohad Ilovich, Ph.D. | Director of Translational Research, Invicro

Kelly Orcutt, Ph.D. | VP of Discovery Research, Invicro

Next Generation Tissue Biomarker Assays to Advance Clinical Drug Development Applications

Kenneth Bloom, M.D., F.A.C.P. | Chief Medical Officer for Advanced Pathology and Genomic Services, Invicro

Optimization of a Novel Tissue Test to Visualize and Quantify Membrane PSMA Expression in  Prostate Cancer

Hemi Dimant, Ph.D. | Director of Applications for Advanced Pathology Services, Invicro

Julie Bailis, Ph.D. | Director of Research, Inflammation/Oncology, Amgen

Uncovering New Biological Insights Using Advanced Pathology Image Analysis Tools

Joseph Krueger, Ph.D. | Vice President, Research and Applications for Advanced Pathology Services, Invicro

Uncovering New Biological Insights Using Advanced Pathology Image Analysis Tools

Joseph Krueger, Ph.D. | Vice President, Research and Applications for Advanced Pathology Services, Invicro

The Digital Biomarker Revolution: How Large-Scale, Clinical-Grade AI Enables Novel CDXs from Histopathology

Thomas Fuchs, Dr.sc. | Founder and Chief Scientific Officer, Paige

Cryofluorescence Tomography: A 3D Imaging Modality and its Applications in Drug Discovery

Robert Holt, Ph.D. | Senior Scientist, Invicro

Hemi Dimant, Ph.D. | Director of Applications for Advanced Pathology Services, Invicro

 

Advanced Biomarker Tools to Support Gene Therapy Research

Matthew Silva, Ph.D. | CEO, Invicro

Kenneth Bloom, M.D., FCAP | Chief Medical Officer of Advanced Pathology and Genomic Services, Invicro

In Vivo and Tissue Molecular Imaging in Gene Therapy

Matthew Silva, Ph.D. | CEO, Invicro

Kenneth Bloom, M.D., FCAP | Chief Medical Officer of Advanced Pathology and Genomic Services, Invicro

Advanced Biomarker Tools to Support Gene Therapy Research

Matthew Silva, Ph.D. | CEO, Invicro

Kenneth Bloom, M.D., FCAP | Chief Medical Officer of Advanced Pathology and Genomic Services, Invicro

Cryofluorescence Tomography: A 3D Imaging Modality and its Applications in Drug Discovery

Robert Holt, Ph.D. | Senior Scientist, Invicro

Hemi Dimant, Ph.D. | Director of Applications for Advanced Pathology Services, Invicro

Novel Quantitative Immunohistochemistry Technology and Associated Applications

Kenneth Bloom, M.D., FCAP | Chief Medical Officer of Advanced Pathology and Genomic Services, Invicro

Novel Quantitative Immunohistochemistry Technology and Associated Applications

Kenneth Bloom, M.D., FCAP | Chief Medical Officer of Advanced Pathology and Genomic Services, Invicro

Optimization of a Novel Tissue Test to Visualize and Quantify Membrane PSMA Expression in  Prostate Cancer

Hemi Dimant, Ph.D. | Director of Applications for Advanced Pathology Services, Invicro

Julie Bailis, Ph.D. | Director of Research, Inflammation/Oncology, Amgen

The Digital Biomarker Revolution: How Large-Scale, Clinical-Grade AI Enables Novel CDXs from Histopathology

Thomas Fuchs, Dr.sc.  | Founder and Chief Scientific Officer, Paige

Imaging Biomarkers in Metastatic Prostate Cancer

Matthew Silva, Ph.D. | CEO, Invicro

Phillip Kuo, M.D., Ph.D. | Senior Medical Director, Invicro

Tissue-based Biomarker Imaging Applications for Oncology Drug Discovery and Development

Joseph Krueger, Ph.D. | VP of Research and Applications for Advanced Pathology Services, Invicro

Next Generation Tissue Biomarker Assays to Advance Clinical Drug Development Applications

Kenneth Bloom, M.D., FCAP | Chief Medical Officer for Advanced Pathology and Genomic Services, Invicro

What’s New in iPACS and VivoQuant With an Eye on the Future

Timothy Moran | Senior Director Product Management, Invicro

Yannick Cadoret | Senior Software Engineer, Invicro

Jonathan Pechan | Senior Product Manager II, Invicro

Deepika Kavety | Software Application Specialist III, Invicro

What’s New in iPACS and VivoQuant With an Eye on the Future

Timothy Moran | Senior Director Product Management, Invicro

Yannick Cadoret | Senior Software Engineer, Invicro

Jonathan Pechan | Senior Product Manager II, Invicro

Deepika Kavety | Software Application Specialist III, Invicro

How MRI is Helping to De-risk Drug Development

Lino Becerra, Ph.D. | VP MRI, Invicro

Rapid in vivo Screening of Gene Delivery, Anticancer Efficacy and Cell Trafficking Using Bioluminescence Imaging

Patrick McConville, Ph.D. | VP, Non-clinical Research Services and Professor of Practice, Radiology, Invicro

Nina Timberlake, Ph.D. | Senior Scientist, Poseida Therapeutics

The Evolution of Lymphoma-Based Oncology Response Criteria

Ashley Bonica Ferreira, RN, BSN | Principal, Merigold
 
Julie C. Gillis, MPH | Lead Consultant, Merigold
 
Gisela Montgomery, M.D., PH.D. | Medical Director, Scientific and Medical Services, Invicro

EXPLORER as a Transformational Imaging Technology for Drug Development

Simon R. Cherry, Ph.D. | Professor, Department of Biomedical Engineering and Department of Radiology, University of California, Davis
 
Roger Gunn, Ph.D. | Chief Scientific Officer, Neuroscience, Invicro

The Resurgence of Theranostics: Challenges and Successes of Clinical Application

Deborah Charych, Ph.D. | Founder and Chief Technology Officer, RayzeBio

Germo Gericke, M.D. | Chief Medical Officer of Advanced Accelerator Applications, Novartis

Ohad Ilovich, Ph.D. | Senior Director of Translational Research, Invicro

John Valliant, Ph.D. | Founder and Chief Executive Officer, Fusion Pharmaceuticals

Moderator:  Arsalan Arif | Publisher & Founder, Endpoint News